Company

Biotech Acquisition Company

Headquarters: New York, NY, United States

CEO: Dr. Michael Shleifer Ph.D.

NASDAQ: BIOT +2.22%

Market Cap

$291.8 Million

USD as of Feb. 1, 2023

Market Cap History

Biotech Acquisition Company Categories

United States Financials Shell Companies
United States Financials United States Shell Companies

Biotech Acquisition Company market capitalization over time

Evolution of Biotech Acquisition Company market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Biotech Acquisition Company

Top Competitors by Market Capitalization

Industry: Shell Companies
Company Market Cap (USD)
Pershing Square Tontine Holdings, Ltd. $4.03 B
Soaring Eagle Acquisition Corp $2.46 B
SPK Acquisition Corp $2.13 B
Austerlitz Acquisition Corp II $1.97 B
KKR Acquisition Holdings I Corp $1.73 B
Sector:
Company Market Cap (USD)
Berkshire Hathaway $1.072 T
JPMorgan $894.99 B
Visa $668.67 B
Mastercard $509.08 B
Bank of America $414.42 B

Detailed Description

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

⛩️ Moltgate
Sell the task first.
Automate what repeats.
Publish a paid offer in minutes. Learn what buyers actually pay for before building agents, workflows, or services nobody buys.
Get Started Free
For AI operators, consultants, & service builders

Stocks & Indices

Biotech Acquisition Company has the following listings and related stock indices.


Stock: NASDAQ: BIOT

Details

Headquarters:

545 West 25th Street

20th Floor

New York, NY 10001

United States

Phone: 212 227 1905